SUPT6H and malignant colon neoplasm: SPT6 knockdown significantly sensitized colon cancer cells, SW620, and RKO, to the treatments of chemotherapeutics, 5FU, and oxaliplatin, leading to a significant reduction in their IC50s (Fig. 3F–G, Fig. S2B).